Purification of monoclonal antibodies from mouse ascites eliminates contaminating infectious mouse type C viruses and nucleic acids
- PMID: 6201307
- PMCID: PMC1535973
Purification of monoclonal antibodies from mouse ascites eliminates contaminating infectious mouse type C viruses and nucleic acids
Abstract
We examined the fate of infectious mouse type C viruses (MuLV) and nucleic acids during the purification of monoclonal antibodies (MoAbs) from mouse ascites. Hybridoma cell lines and their cell fluids can contain infectious ecotropic and xenotropic MuLV whose presence in ascitic fluid may be masked by the presence of anti-viral factors, particularly the anti-xenotropic virus neutralizing factor. They can also contain DNA and RNA. The specific techniques we used for the purification of MoAbs from the ascitic fluid completely eliminated all detectable infectious MuLV, anti-viral factors, and nucleic acids, even when these agents were added in quantities far in excess of those normally expected. Viral proteins, potentially contaminating the MoAb preparations, were also substantially reduced by our procedures. Because infectious MuLV or nucleic acids may have adverse effects on human subjects, attention should be given to each MoAb purification process to insure their effective removal.
Similar articles
-
Viral contamination of monoclonal antibody preparations: potential problems and possible solutions.Cytotechnology. 1990 Jul;4(1):3-12. doi: 10.1007/BF00148806. Cytotechnology. 1990. PMID: 1366721 Review. No abstract available.
-
Presence of the inflammatory cytokines IL-1, TNF, and IL-6 in preparations of monoclonal antibodies.Hybridoma. 1989 Jun;8(3):361-7. doi: 10.1089/hyb.1989.8.361. Hybridoma. 1989. PMID: 2663704
-
Immunologic mechanisms in the pathogenesis of virus-induced leukemia. IV. Mechanism of target cell recognition by autoreactive thymocytes.J Immunol. 1985 Jun;134(6):4244-9. J Immunol. 1985. PMID: 3872912
-
Some ascites monoclonal antibody preparations contain contaminants that bind to selected Golgi zones or mast cells.J Histochem Cytochem. 1994 Feb;42(2):213-21. doi: 10.1177/42.2.7507139. J Histochem Cytochem. 1994. PMID: 7507139
-
Monoclonal antibody supernatant and ascites fluid production.Curr Protoc Immunol. 2001 May;Chapter 2:2.6.1-2.6.9. doi: 10.1002/0471142735.im0206s40. Curr Protoc Immunol. 2001. PMID: 18432770 Review.
Cited by
-
Viral contamination of monoclonal antibody preparations: potential problems and possible solutions.Cytotechnology. 1990 Jul;4(1):3-12. doi: 10.1007/BF00148806. Cytotechnology. 1990. PMID: 1366721 Review. No abstract available.
-
Monoclonal antibodies--therapeutic and diagnostic uses in malignancy.West J Med. 1985 Dec;143(6):810-8. West J Med. 1985. PMID: 3911594 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources